Educational Activities Archives

Filter by Target Audience Information
Filter by Target Audience

Please select the option that best aligns with your profession.

Target Audience
Filter by Topic Information
Filter by Topic

Please select the option that best aligns with your topic of interest.

Click on the plus (+) icon to display subtopics.

Filter by Format Information
Filter by Format

Please select the option that best aligns with your preferred format of training.

Formats
Key Term Search Information
Key Term Search

Use the search bar to enter in the title of a training, or other key terms.

Course and Resource Listing

Back to Filter ^

Medical Considerations for Patients with Opioid Use Disorder

Format: Module
This module reviews features of skin and soft tissue infections among people who inject drugs, reviews risk factors for Hepatitis C (HCV) and HIV, describes prevention interventions for HCV and HIV, and discusses treatment approaches for HCV and HIV in patients with opioid use disorder.
Target Audience(s):
Interprofessional Teams, Nurses, PAs, Pharmacists, Physicians, Students and Educators
Topic(s):
Co-Occurring SUD / Medical Disorders, Cardiovascular, Ethics, General Medical Comorbidities, Hepatic, Infectious Disease, Stigma, SUD Core Curriculum, Supplemental ...
Presenter(s):
Jeanette M. Tetrault, MD, FACP, FASAM, Professor of Medicine and Public Health, Yale School of Medicine
Credit Available:
CE Credit(s): Yes
Designations: AMA PRA Category 1 Creditâ„¢, AAPA Category 1 CME, Nursing Contact Hours, Pharmacy CE Credit, Interprofessional Continuing Education (IPCE) Credit
Organizer(s):
American Academy of Addiction Psychiatry

Integrating Care: The Role of MOUD in Addressing Opioid Use Disorder and Infectious Disease

Format: Webinar
Due to the opioid epidemic, over 2.5 million adults in the U.S. have opioid use disorder (OUD), yet only 25% of those who need treatment receive recommended medication for opioid use disorder (MOUD). Alongside the rising rates of OUD, there has been an increase in infectious diseases such as HIV, hepatitis B and C, endocarditis and skin and soft-tissue infections, particularly among people who inject drugs. These intertwining epidemics have not been sufficiently addressed, but MOUD — combined with appropriate substance use treatment supports and health care services — represents an opportunity to reduce risk and improve health outcomes.
Target Audience(s):
Administrative Staff, Counselors, Family and Patient, Interprofessional Teams, Nurses, PAs, Pharmacists, Pharmacy Technicians, Physicians, Psychiatrists, Psychologists, Social Workers, Students and Educators
Topic(s):
Co-Occurring SUD / Medical Disorders, ASAM Criteria, Assessment, Buprenorphine, Cardiovascular, Emergency Setting, Endocrine and Metabolic, General Medical Comorbidities, Hepatic, Hospital Setting ...
Presenter(s):
Daniel Rosa, MD
Credit Available:
CE Credit(s): No
Certificate: Certificate of Attendance, 1-hour
Organizer(s):
National Council for Mental Wellbeing

Hepatitis C – FAQs, Statistics, Data, & Guidelines

Format: Clinical Tool
CDC Guidances and Resources
Target Audience(s):
Nurses, Family and Patient, Physicians, Psychiatrists, Psychologists, Social Workers
Topic(s):
Co-Occurring SUD / Medical Disorders, General Medical Comorbidities, Hepatic ...
Credit Available:
CE Credit(s): No
Certificate: No

Outcomes of Treatment for Hepatitis C Virus Infection by Primary Care Providers

Format: Clinical Tool
View the Abstract.
Target Audience(s):
PAs, Physicians, Psychiatrists, Students and Educators
Topic(s):
Co-Occurring SUD / Medical Disorders, General Medical Comorbidities, Hepatic, Hospitalist ...
Credit Available:
CE Credit(s): No
Certificate: No

Monitoring of Liver Function Tests in Patients Receiving Naltrexone or Extended-Release Naltrexone

Format: Clinical Tool
How should I monitor liver function tests in patients who are receiving naltrexone or extended-release naltrexone for their treatment of opioid and or alcohol use disorders? What should I do if a patient receiving naltrexone does develop evidence of a severe elevation of liver function tests or acute hepatitis?
Target Audience(s):
Physicians, Psychiatrists
Topic(s):
Co-Occurring SUD / Medical Disorders, Alcohol, General Medical Comorbidities, Hepatic, Infectious Disease, Medications, Naltrexone, Naltrexone, Opioids, Treatment ...
Credit Available:
CE Credit(s): No
Certificate: No

Monitoring of Liver Function Tests and Hepatitis in Patients Receiving Buprenorphine/Naloxone

Format: Clinical Tool
How should I monitor liver function tests in patients with or without underlying chronic hepatitis who are receiving buprenorphine for the treatment of opioid dependence? What should I do if a patient receiving buprenorphine does develop evidence of acute hepatitis or worsening chronic hepatitis?
Target Audience(s):
Physicians, Psychiatrists
Topic(s):
Co-Occurring SUD / Medical Disorders, Buprenorphine, General Medical Comorbidities, Hepatic, Infectious Disease, Medications, Opioids, Treatment ...
Credit Available:
CE Credit(s): No
Certificate: No
More Results